Revenio Group Corporation - Asset Resilience Ratio
Revenio Group Corporation (REG1V) has an Asset Resilience Ratio of 15.89% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Revenio Group Corporation carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2022)
This chart shows how Revenio Group Corporation's Asset Resilience Ratio has changed over time. See Revenio Group Corporation book value and equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Revenio Group Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Revenio Group Corporation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €22.20 Million | 15.89% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €22.20 Million | 15.89% |
Asset Resilience Insights
- Good Liquidity Position: Revenio Group Corporation maintains a healthy 15.89% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Revenio Group Corporation Industry Peers by Asset Resilience Ratio
Compare Revenio Group Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Envoy Medical Inc.
NASDAQ:COCH |
Medical Devices | 0.53% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Revenio Group Corporation (2000–2022)
The table below shows the annual Asset Resilience Ratio data for Revenio Group Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 23.43% | €31.89 Million ≈ $37.28 Million |
€136.09 Million ≈ $159.10 Million |
+3.19pp |
| 2021-12-31 | 20.24% | €25.22 Million ≈ $29.48 Million |
€124.58 Million ≈ $145.65 Million |
-26.51pp |
| 2009-12-31 | 46.75% | €12.42 Million ≈ $14.52 Million |
€26.57 Million ≈ $31.06 Million |
+0.93pp |
| 2008-12-31 | 45.82% | €13.26 Million ≈ $15.50 Million |
€28.94 Million ≈ $33.83 Million |
+43.99pp |
| 2001-12-31 | 1.83% | €453.00K ≈ $529.60K |
€24.79 Million ≈ $28.98 Million |
-2.49pp |
| 2001-09-30 | 4.32% | €1.71 Million ≈ $2.00 Million |
€39.63 Million ≈ $46.34 Million |
-6.94pp |
| 2000-12-31 | 11.27% | €5.04 Million ≈ $5.90 Million |
€44.76 Million ≈ $52.33 Million |
-- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pre… Read more